Senior Management Led | Transactions

Histogenics

$9,000,000 Series B Preferred Investment From a Group Led by

Exclusive Placement Agent for Histogenics

More Transactions

Has been acquired by

Outcome Capital facilitates acquisition as sole strategic and financial advisor to ERS

Has been acquired by

Financial Advisor to Innara Health
Elios

$32 Million

Has Completed a Growth Equity Financing

The undersigned acted as exclusive strategic & financial advisor to ELIOS Vision, Inc.

Has Completed an Oversubscribed Growth Equity Round

The undersigned acted as exclusive strategic & financial advisor to NanoHive Medical, LLC.

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    20 Custom House St, Suite 12, Boston, MA 02110
    (617) 431-2278

© Outcome Capital 2023. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.

Business Continuity Plan | Privacy Policy | Regulation Best Interest

Built by Metropolis